A vaccine against papilloma virus for adults?

A vaccine against HPV 16 has been created for the older generationABC
The first studies of a new experimental vaccine against human papillomavirus (HPV) have shown positive results.

The vaccine was administered to 20 women already infected with the human papillomavirus with a predominance of HPV 16 and who had symptoms of disease progression (intraepithelial neoplasia of the vulva). The researchers claim that over a two–year period of research, they managed to achieve a significant regression of the disease, and in some cases, a complete cure.

Already three months after the start of the vaccination cycle, 5 patients completely lost symptoms of the disease, and 4 of them could not even detect HPV 16. Two years later, half of the women from the experimental group were declared completely cured. The researchers consider their results to be very promising.

To date, two HPV vaccines launched for sale are designed to protect against primary infection of the female body with certain strains of the virus that can lead to the development of cervical cancer. Vaccines are useless in the case of the human papillomavirus already present in the body, therefore, the Centers for Disease Control (CDC) recommend vaccinating girls aged 11-12 and consider it useless to administer the vaccine to women over 26 years old. Perhaps the new vaccine will be a salvation for older women.

The results of the study (Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia) were published in The New England Journal of Medicine NEJM, V. 361:1838-1847, No. 19. 5.11.2009.

Portal "Eternal youth" http://vechnayamolodost.ru06.11.2009